These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3511695)

  • 21. The role of calcium channel blockers in the treatment of hypertension.
    Halperin AK; Cubeddu LX
    Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience.
    Colucci WS; Fifer MA; Lorell BH; Wynne J
    Am J Med; 1985 Feb; 78(2B):9-17. PubMed ID: 3976695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of calcium channel blocking agents on cardiovascular function.
    Low RI; Takeda P; Mason DT; DeMaria AN
    Am J Cardiol; 1982 Feb; 49(3):547-53. PubMed ID: 7058766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
    Jacob LP; Malhotra D; Chan L; Shapiro JI
    Am J Kidney Dis; 1999 Feb; 33(2):301-3. PubMed ID: 10023642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem.
    Suryapranata H; Serruys PW; Soward AL; Planellas J; Vanhaleweyk G; Hugenholtz PG
    Aust N Z J Med; 1985 Dec; 15(6):685-90. PubMed ID: 3869435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD
    Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
    Silke B; Frais MA; Midtbo KA; Verma SP; Sharma S; Reynolds G; Jackson N; Taylor SH
    Clin Pharmacol Ther; 1987 Oct; 42(4):381-7. PubMed ID: 2959425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 33. Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure.
    Magorien RD; Leier CV; Kolibash AJ; Barbush TJ; Unverferth DV
    Circulation; 1984 Nov; 70(5):884-90. PubMed ID: 6488501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium entry blockers: a review.
    Goad DL
    J Vet Pharmacol Ther; 1982 Dec; 5(4):233-9. PubMed ID: 6306265
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change in inotropic and chronotropic function of the heart and resistance of the coronary vessels during combined use of Ca2+ antagonists].
    Tkachenko BI; Kostko SZ; Katsenovich RA; Stepanova TG; Shil'kurt BL
    Biull Eksp Biol Med; 1991 Jun; 111(6):584-6. PubMed ID: 1893174
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of slow channel blocking agents.
    McAllister RG
    Prog Cardiovasc Dis; 1982; 25(2):83-102. PubMed ID: 7051139
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slow channel blockers.
    Covinsky JO; Hamburger SC
    South Med J; 1983 Jan; 76(1):55-64. PubMed ID: 6337401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.